1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide (CAS No: 1640981-20-9) is a key pharmaceutical intermediate used in the synthesis of APIs Tegoprazan. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 4-Hydroxy-N,N,2-trimethyl-1-(phenylmethyl)-1H-benzimidazole-6-carboxamide, 1H-Benzimidazole-6-carboxamide, 4-hydroxy-N,N,2-trimethyl-1-(phenylmethyl)-
CAS No: 1640981-20-9
PubChem CID: 117800546
Mol Formula: C18H19N3O2
Mol Weight: 309.4 g/mol
Used in API: Tegoprazan
IUPAC Name: 3-benzyl-7-hydroxy-N,N,2-trimethylbenzimidazole-5-carboxamide
API Intermediate Description: 1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide is a substituted benzimidazole derivative featuring a hydroxyl group, a benzyl moiety, and a carboxamide functional group. The combination of these substituents modulates its electronic properties, solubility, and potential bioactivity. It is mainly used as an intermediate or active scaffold in pharmaceutical and medicinal chemistry research.